- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03559829
Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke
Regaining upper extremity function is very important for stroke survivors to increase their independence and ability to perform activities of daily living (ADLs). Outpatient stroke rehabilitation currently takes place in a therapy clinic, however access can be limited by financial resources and transportation difficulties.
The Feasibility of Home-Based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke Study seeks to explore the safety, usability, and efficacy of a home based virtual reality biofeedback system to promote distal upper extremity (wrist and hand) recovery after stroke. The purpose of the study is to assess the feasibility of using a home-based virtual reality system to increase the dose of upper extremity rehabilitation in subacute and chronic stroke patients.
Study Overview
Detailed Description
In this pilot study, we propose to test a virtual reality home-based intervention as an alternative or supplement to traditional rehabilitation for upper extremity weakness after stroke. We are hoping to discover that the device is easily adopted by patients and increases the dose of rehabilitation, as well as potentially leads to motor recovery.
With the increasing affordability and accessibility of virtual reality (VR) systems, VR has emerged as a new platform for stroke rehabilitation. VR therapy involves using computer-based programs to simulate daily tasks and events. VR has shown promise in both allowing patients to practice activities that directly translate to their ADLs, as well as motivating them by providing a novel and interesting virtual environment.
Relevance Regaining upper extremity function is very important for stroke survivors to increase their independence and ability to perform ADLs. The large majority of outpatient stroke rehabilitation currently takes place in a therapy clinic, however access is often limited by resource allocation, financial hardship, and transportation difficulties. The Smart Glove can provide an inexpensive and convenient means for stroke patients to continue their rehabilitation in the comfort of their own home.
Patient Population Subacute and chronic stroke patients presenting with upper extremity weakness, as identified by Stanford physicians in clinic, will be eligible for participation in this study. Patients will be screened and selected from the population of people with strokes who are seen in the Stanford Neuroscience Clinic. Patients will be allowed to participate in any scheduled outpatient rehabilitation during the study. The doctor and/or research coordinator may introduce the study to potential candidates in-person in the Stanford Neurology Clinic, and the research coordinator may contact potential candidates by phone after the doctor's referral.
Procedures:
Once the participant has given informed consent and enrolled in the study, they will have a total of five visits, with one visit every two weeks.
Visit one will entail the participant and identified caregiver undergoing training on the use of the Smart Glove by the research coordinator and Neofect staff. This involves donning/doffing of the glove as well as instruction as to how to use the software program. The participant will be issued a Smart Glove and a tablet preloaded with the software. Subjects will also undergo baseline functional testing, including manual muscle testing (MMT), Fugl-Meyer assessment (FM), Jebsen-Taylor hand function test (JTT), and Stroke Impact Scale (SIS). This first visit is expected to take 60-90 minutes. The participant will be expected to use the Smart Glove for 60 min per day for at least 5 days per week.
The subsequent three visits will be at two week intervals and will involve the participant bringing the device to the Clinical and Translational Research Unit (CTRU). The research coordinator will upload the data from the device as well as troubleshoot any device-related issues. These visits will last 15-30 minutes each.
The final visit will occur after eight weeks of Smart Glove use. In addition to downloading the data, the research coordinator will also repeat functional testing functional testing, including manual muscle testing (MMT), Fugl-Meyer assessment (FM), Jebsen-Taylor hand function test (JTT), and Stroke Impact Scale (SIS). This visit will last 45-60 minutes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford Hospital and Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1) Age 18 and older 2) Diagnosis of stroke at least three months prior to enrollment 3) Unilateral upper extremity functional deficit after stroke 4) Presence of a score of at least 2 points on the medical research council scale for wrist flexion/extension or forearm pronation/supination 5) Able to provide informed consent 6) Caregiver who is willing to be trained in use of the Smart Glove
Exclusion Criteria:
- 1) Predisposing psychological disorders which could impede participation 2) Severe aphasia resulting in communication difficulties 3) Severe pain impeding upper extremity rehabilitation 4) Pre-existing neurological disorder that causes motor deficits (i.e. Parkinson's disease)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single Arm - Intervention arm
RAPAEL Smart Glove Arm The participant will be issued a Smart Glove and a tablet preloaded with the game software.
The available games provide various kinds of motion tasks such as ADL-related tasks presented in an entertaining manner.
The learning schedule algorithm automatically adjusts to the optimal level of difficulty to balance challenge and motivation.
The participant will be expected to use the Smart Glove at home for 60 min per day for at least 5 days per week.
|
The RAPAEL Smart Glove is a commercially available, non-invasive biofeedback based system for distal upper extremity rehabilitation.
The Smart Glove is very lightweight and allows for easy movement of all distal upper extremity joints.
It is made of an elastomer material that is simple to maintain and clean.
The Bending Sensor is a variable resistor that changes as it is bent.
The sensor is a 9-axis movement and position sensor that consists of 3 acceleration channels, 3 angular rate channels, and 3 magnetic field channels that measure wrist movements.
They are connected to a computer system which can accurately compute the amount of individual finger movements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Device Use
Time Frame: 8 weeks
|
Number of days during 8 week study-period that patient used the device.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Device Use Daily Average Per Use Day
Time Frame: 8 weeks
|
Daily average number of minutes of device-use per days that device was used.
|
8 weeks
|
|
Device Use Daily Average
Time Frame: 8 weeks
|
Daily average number of minutes of device-use during 8-week intervention period.
|
8 weeks
|
|
Jebsen-Taylor Hand Function Test - Overall Score
Time Frame: 8 weeks
|
Time (in seconds) to complete the total Jebsen-Taylor Hand Function Test administered at 8-weeks.
The test consists of 7 subtests.
Each subtest is allotted a maximum time of 90 seconds.
The total score is the sum of the scores of the seven subtests.
The total score has a maximum of 630 seconds and there is no minimum.
Longer time to complete the test indicates worse hand function.
|
8 weeks
|
|
Jebsen-Taylor Hand Function Test - Fine Score
Time Frame: 8 weeks
|
Time (in seconds) to complete the four fine-motor subtests of the Jebsen-Taylor Hand Function Test administered at 8-weeks.
Each of the four subtests is allotted a maximum time of 90 seconds.
The total score is the sum of the scores of the four subtests.
The total score has a maximum of 360 seconds and there is no minimum.
Longer time to complete the test indicates worse hand function.
|
8 weeks
|
|
Jebsen-Taylor Hand Function Test - Gross Score
Time Frame: 8 weeks
|
Time (in seconds) to complete the three gross-motor subtests of the Jebsen-Taylor Hand Function Test administered at 8-weeks.
Each of the three gross-motor subtests is allotted a maximum time of 90 seconds.
The total gross-motor score is the sum of the scores of the three subtests.
The total score has a maximum of 270 seconds and there is no minimum.
Longer time to complete the test indicates worse hand function.
|
8 weeks
|
|
Fugl-Meyer Assessment
Time Frame: 8 weeks
|
Upper Extremity Fugl-Meyer Test score at 8-weeks.
Score ranges from 0 to 66, with higher scores corresponding to better arm function.
|
8 weeks
|
|
Manual Muscle Testing (MMT) Score
Time Frame: 8 weeks
|
The MMT score is the sum of the Medical Research Council (MRC) scores across 5 domains (elbow flexor, elbow extensor, wrist extension, finger extension and finger flexion) at 8 weeks.
Each domain has a scale range of 0 to 5, with higher scores corresponding to better strength.
Maximum MMT score ranges from 0-25, with higher scores corresponding to better strength.
|
8 weeks
|
|
Stroke Impact Scale (SIS)
Time Frame: 8 weeks
|
Score on the SIS at 8-weeks.
The score ranges from 0 to 100, with higher scores corresponding to better recovery from stroke.
|
8 weeks
|
|
Patient Experience
Time Frame: 8 weeks
|
Patient self-reported satisfaction with device use (5-point Likert Scale, with higher scores indicating greater satisfaction).
|
8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kara Flavin, MD, Stanford University
- Principal Investigator: Maarten Lansberg, MD, Stanford University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 37580
- 125802 (Other Identifier: Stanford)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
Clinical Trials on RAPAEL Smart Glove
-
Stanford UniversityNEOFECT Rehabilitation SolutionsCompletedCerebral Infarction | Stroke, AcuteBelgium, United States
-
National Rehabilitation Center, Seoul, KoreaUnknownUpper Extremity Rehabilitation Using SMART Glove System With Transcranial Direct Current StimulationStrokeKorea, Republic of
-
Carol Davila University of Medicine and PharmacyHospices Civils de LyonNot yet recruiting
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterTerminatedStroke | HemiplegiaKorea, Republic of
-
Moscow Scientific and Practical Center of Medical...RecruitingStroke RehabilitationRussian Federation
-
University of TurkuAalto UniversityCompleted
-
Samsung Medical CenterKorea Health Industry Development InstituteRecruitingHome Based Rehabilitation | Brain DisorderSouth Korea
-
Pusan National UniversitySamsung Medical Center; NEOFECT Rehabilitation Solutions; Sungkyunkwan UniversityUnknownStroke | Cerebral Vascular AccidentKorea, Republic of
-
Shirley Ryan AbilityLabActive, not recruitingSpinal Cord InjuriesUnited States
-
National Rehabilitation Center, Seoul, KoreaUnknown